Article
10 Dec 2025
USPTO Revises Guidance On AI-Assisted Inventorship
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
09 Dec 2025
FDA's Biosimilar Playbook: Merging Biosimilarity With Interchangeability
Article
06 Nov 2025
FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development
Article
03 Oct 2025
Federal Circuit Clarifies Limits On Patentability Of Clinical Study Results-Based Applications
Article
28 Aug 2025
Bill Seeks To Restrict 30-Month Stay In Hatch-Waxman Litigation To One Patent
Article
31 Jul 2025
Congress Expands Orphan Drug Exemptions From Medicare Price Negotiations
Article
07 Apr 2025
PTAB Announces A Bifurcated Process For Consideration Of IPR And PGR Petitions
Article
02 Apr 2025
PTAB Announces Bifurcated Process For Consideration Of Discretionary Denial Issues
Article
28 Jan 2025
USPTO Launches Significant Patent Fee Increases
Article
10 Dec 2024
USPTO Withdraws Proposal To Add New Terminal Disclaimer Requirements
Article
11 Oct 2024
Supreme Court Denies Cellect Petition On Interplay Between PTA And ODP
Article
18 Sep 2024
USPTO Extends Comment Deadline On Patent Eligible Subject Matter Guidance For AI Inventions
Article
31 Jul 2024
U.S. Senate Unanimously Passes Bill Limiting Number Of Patents Asserted Against Biosimilar Applicants
Article
22 Jul 2024
USPTO Issues Patent Eligible Subject Matter Guidance For AI Inventions
Article
11 Jul 2024
USPTO Requests Comments On The Experimental Use Exception
Article
31 May 2024
NIH Seeks Comments On Patient Access Plan Requirements In Patent License Agreements
Article
28 May 2024
Canadian Drug Importation May Undermine Intellectual Property Protection
Article
16 May 2024
Higher Burden Of Demonstrating Public Accessibility Of A Reference At Final Decision Stage
Article
07 May 2024
USPTO Announces Request For Comments: AI's Impact On Prior Art And The PHOSITA
Article
01 Feb 2024
Federal Circuit Denies Petition For Rehearing En Banc Filed By Cellect, LLC